08/18/2026
The FAA has proposed new rules for emergency medical kits aboard commercial aircraft. While the proposal recognizes anaphylaxis as a life-threatening emergency airlines must be prepared to treat, it does NOT clearly require epinephrine to be available on every flight.
The proposed rule moves away from a clear requirement to carry epinephrine and instead allows for treatment options that MAY include it — despite longstanding concerns about access to epinephrine during in-flight emergencies.
This is not only about passengers who already know they have an allergy. Someone with an undiagnosed allergy can experience their first-ever anaphylactic reaction on a flight, and the aircraft’s emergency medical kit may be the only source of lifesaving treatment available.
Or maybe someone administers their own epi but needs another dose.
Passengers and crew should not have to wonder whether it is onboard, whether someone knows how to draw the correct dose from a vial, or whether the right delivery option is available.
**The public has until October 5, 2026, to make its voice heard.**
We urge the food allergy community — and everyone who believes passengers deserve access to lifesaving emergency treatment — to submit a public comment asking the FAA to require:
🔴 Epinephrine on every commercial passenger aircraft
🔴 Dosing for children AND adults
🔴 A modern, easy-to-use delivery option that can be administered quickly in an emergency
🔴 Clear, consistent standards across airlines
Access to epinephrine should not depend on which airline you happen to be flying. It should be on EVERY flight, period.
Speak up before October 5. Your comment can help shape the final rule and make air travel safer for everyone.
👉 Leave a public comment here:
https://www.federalregister.gov/documents/2026/08/05/2026-15929/improving-emergency-medical-kit-efficacy-and-flexibility-in-commercial-airline-operations #
FAA Docket: FAA-2026-9178